AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glycicheck M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Astorion Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glycicheck M 2mg/500mg Tablet

Diabetam Duo 2mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabetam Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.

Uses of Glycicheck M 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glycicheck M 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glycicheck M 2mg/500mg Tablets. Ingest the tablets whole; do not crush, chew, or break them. Administer this medication with a meal.

Common Side effects of Glycicheck M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glycicheck M 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glycicheck M 2mg/500mg tablets with food.

How Glycicheck M 2mg/500mg Tablet works:

Glycicheck M 2mg/500mg tablets combine the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose output, retarding intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glycicheck M 2mg/500mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glycicheck M 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated with Glycicheck M 2mg/500mg tablets due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glycicheck M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is necessary. Glycicheck M 2mg/500mg tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glycicheck M 2mg/500mg tablets cautiously. Dosage modification may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, Glycicheck M 2mg/500mg tablets are typically initiated at a low dose; however, its use is contraindicated in patients with severe liver dysfunction.

What if you forget to take Glycicheck M 2mg/500mg Tablet :

Should you forget to take a Glycicheck M 2mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glycicheck M 2mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glycicheck M 2mg/500mg Tablet

Retain this medication within its original, tightly sealed container or packaging. Follow the storage guidelines specified on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Lactic acidosis, a serious medical condition stemming from excessive blood lactic acid, is a potential consequence of Glycicheck M 2mg/500mg Tablet use. This adverse reaction, also termed Metformin-associated lactic acidosis (MALA), though infrequent, poses a significant risk to individuals with pre-existing kidney impairment, the elderly, or those who consume substantial alcohol. Characteristic symptoms include muscular discomfort or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, and bradycardia. Should these symptoms appear, discontinue Glycicheck M 2mg/500mg Tablet use and seek immediate medical attention.
Glycicheck M 2mg/500mg tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action medication enhances blood sugar control when used in conjunction with a balanced diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for individuals with type 1 diabetes.
Glycicheck M 2mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged administration may result in vitamin B12 deficiency.
Glycicheck M 2mg/500mg Tablet's prolonged use can indeed lead to Vitamin B12 deficiency by hindering its absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may result in anemia, neurological complications such as peripheral neuropathy (manifesting as tingling, numbness in extremities, and weakness), urinary dysfunction, cognitive changes, and gait instability. Prophylactic Vitamin B12 supplementation, at least annually, is recommended by some studies to mitigate these risks.
Indeed, Glycicheck M 2mg/500mg Tablets can induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available simple carbohydrate source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Glycicheck M 2mg/500mg tablets and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Alcohol consumption can also heighten the likelihood of lactic acidosis.
Glycicheck M 2mg/500mg Ta...
107
MRP 130
17% off